Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and ...

Advanced therapies, medicines bring new hope for pulmonary hypertension patients: Dr Manisha Mendiratta: Shardul Nautiyal, Mumbai Saturday, February 8, 2025, 08:00 Hrs [IST] Dr Ma ...

Seropositive rheumatoid arthritis may be protective against the development of PAH, based on results of Mendelian randomization analyses.

Heart disease is the leading cause of death for men and women in the United States, and to raise awareness, the National ...

Women are more likely to have pulmonary arterial hypertension, but men tend to have worse outcomes and worse treatment responses.

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) ...

United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

Patients with congenital heart disease associated PAH tend to have ... FC: Functional class; iPAH: Idiopathic pulmonary arterial hypertension; iv.: Intravenous; NYHA: New York Heart Association ...

The HYPERION study will be stopped early due to positive efficacy data from across the sotatercept clinical program.

Mount Carmel’s heart and vascular teams have debuted several new, highly advanced surgical procedures in Central Ohio.

Medera, Inc., (“Medera”), a clinical-stage biotechnology company, announced today that the management team will participate ...

Chair and CEO of Insmed Inc. (NASDAQ:INSM), recently executed a significant stock transaction amid the company's impressive 178% stock surge over the past year. According to a recent SEC filing, Lewis ...